Feb 05, 2025 / 02:00PM GMT
Operator
Good morning, and welcome to the Bio-Techne conference call for the second quarter of fiscal year 2025. (Operator Instructions) I would now like to turn the call over to David Clair, Bio-Techne's Vice President, Investor Relations.
David Clair - Bio-Techne Corp - Investor Relations
Good morning, and thank you for joining us. On the call with me this morning are Kim Kelderman, President and Chief Executive Officer; and Jim Hippel, Chief Financial Officer of Bio-Techne.
Before we begin, let me briefly cover our Safe Harbor statement. Some of the comments made during this conference call may be consider ward-looking statements, including beliefs and expectations about the company's future results. The company's 10-K for fiscal year 2024 identify certain is that could cause the company's actual results to differ materially from those projected in the forward-looking statements made during this call.
The company does not undertake to update any forward-looking statements because of any new information or future events or developments. The 10-K as
Q2 2025 Bio-Techne Corp Earnings Call Transcript
Feb 05, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers